Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials
Abstract Background Polycystic ovary syndrome (PCOS) is an endocrine disorder affecting about 10% of women in reproductive age and associated with a variety of hormonal abnormalities, including hyperandrogenemia and infertility, all of which could lead to PCOS. Statins were previously introduced as...
Main Authors: | Hussain H. Almalki, Turki M. Alshibani, Abdullah A. Alhifany, Omar A. Almohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12905-020-00919-5 |
Similar Items
-
Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
by: Dorte Glintborg, et al.
Published: (2017-06-01) -
Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
by: Ferdous Mehrabian, et al.
Published: (2016-01-01) -
A comparison between the effect of trans-anethole and metformin on biochemical parameters of polycystic ovary syndrome in rats
by: Faezeh Moradi Negahdari, et al.
Published: (2021-09-01) -
Effects of metformin use in pregnant patients with polycystic ovary syndrome
by: Pratap Kumar, et al.
Published: (2012-01-01) -
Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
by: Charikleia Stefanaki, et al.
Published: (2019-09-01)